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Abstract
Background. Routine preoperative biliary drainage in cases of jaundice secondary to pancreatobiliary malignancy is
associated with a significant risk of complications, failure and stent occlusion. It may be possible to avoid biliary drainage in
those patients who are not deeply jaundiced. Aims. To measure presenting serum bilirubin and its rate of increase in patients
with malignant obstructive jaundice. To predict the urgency with which surgery should be performed to avoid preoperative
biliary drainage. Patients and methods. Prospective data collection for all pancreatic and periampullary malignancies over a
period of 18 months was carried out. Serum bilirubin levels before successful drainage were recorded. Rates of increase in
bilirubin and the number of days for bilirubin to reach different thresholds were calculated. Results. Of 111 patients, 66
(59%) had resectable disease on imaging investigations. Median serum bilirubin on presentation was 160 mmol/l. Median
increase was 13.1 mmol/l/day or approximately 100 mmol/l/week. The predicted number of days for bilirubin levels to reach a
variety of thresholds varied significantly. For a patient presenting with a serum bilirubin of 160 mmol/l, the mean number of
days for it to rise to 200 mmol/l, 300 mmol/l, 400 mmol/l and 500 mmol/l was 3, 13, 22 and 31 days, respectively. Conclusions.
There is a variable window of opportunity in jaundiced patients with pancreatic and periampullary malignancy during which
surgery may be performed to avoid biliary drainage procedures, depending on the threshold for operating on the jaundiced
patient.
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Introduction
In patients undergoing surgical procedures for pan-
creatic and periampullary malignancy the presence of
jaundice has been shown to be associated with a higher
incidence of septic, renal and nutritional complica-
tions [13]. The depth of jaundice has been shown to
correlate positively with mortality after surgical inter-
vention in benign disease [1]. It seems likely that the
same is true for malignant pathology, particularly as
increasing jaundice has been shown to be associated
with the same nutritional and septic sequelae that have
adverse effects on surgical outcome [4].
Conventional management of jaundiced patients
with pancreatic and periampullary malignancy has
included the use of biliary drainage procedures,
particularly endoscopic retrograde cholangiopancrea-
tography (ERCP) followed by further assessment and
resectional surgery when possible. ERCP performed
for purely diagnostic reasons has, more recently, been
superceded by other imaging techniques such as CT,
MRI and endoscopic ultrasound. Biliary instrumenta-
tion also carries a significant risk of morbidity and
mortality from complications such as perforation,
cholangitis, haemorrhage and acute pancreatitis.
ERCP is associated with a complication rate of
125% and a mortality rate of 0.21% [515]. In
addition, the procedure has a failure rate of between 3
and 30% [5,6,11,12,1518]. Percutaneous transhe-
patic cholangiography (PTC) is associated with a
complication rate of 2767% with a mortality rate of
up to 6% [15,19,20]. It also carries the additional risk
of tumour seeding along the drain track rendering
potentially curable tumours unresectable [21]. Even
in patients who successfully undergo a complication-
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free drainage procedure, recurrent jaundice and
cholangitis due to stent occlusion is common [22].
Several studies have either shown no effect of
preoperative drainage on outcome after resection
[5,19,2225,34] or a detrimental effect with
increased morbidity, mortality or costs [2628].
Improved postoperative morbidity has been demon-
strated in other studies [2932], with one also
showing evidence of improved cardiac function after
biliary drainage [33]. None of these studies were
randomized trials and none advocating preoperative
biliary drainage suggested a degree of hyperbilirubi-
naemia beyond which drainage should be mandatory.
Most clinicians would agree that the profoundly
jaundiced patient should undergo biliary drainage
before resection, particularly if septic or renal compli-
cations are encountered. However, many patients
present with a mild degree of jaundice that would not,
if it remained stable, preclude surgery from being
performed without preoperative biliary drainage. Com-
plications of drainage could thus be avoided and the
degree of jaundice would not be severe enough to cause
potential increases in postoperative complications.
Because most patients with mild obstructive jaun-
dice of malignant aetiology will progress to severe
jaundice if untreated, the surgeon may have a window
of opportunity to perform a pancreatic resection
without preoperative biliary drainage. This would
assume that such patients could be identified early
and management implemented before the jaundice
progressed to a level that made drainage necessary.
Consequently, a prospective study was carried out
over an 18-month period, the aims of which were: (1)
to determine the rate of increase of serum bilirubin
levels in patients with pancreatic and periampullary
malignancy and (2) to predict the length of time after
presentation during which surgery could be carried
out in order to avoid the use of biliary drainage
procedures.
Patients and methods
Patients and measurements
Over the period of June 2002 to December 2003
inclusive, data were collected prospectively on all
cases of suspected pancreatic and periampullary
malignancy presenting with obstructive jaundice to a
large cancer centre experienced in the treatment of
such tumours. All serum bilirubin levels measured
either by general practitioners, referring hospitals or
within the cancer centre were recorded before suc-
cessful biliary drainage or surgical intervention. All
investigations and procedures were undertaken on
purely clinical grounds.
Statistical methods
Rates of increase of serum bilirubin. Bilirubin levels from
presentation to maximum readings were first plotted
and seen to best fit to a linear model. Linear and
logistic regression analysis was then carried out to
determine the relationship between the level of serum
bilirubin on presentation and the subsequent rate of
increase. Rates of increase in bilirubin were calculated
for each patient and compared on resectable and non-
resectable patients using Student’s t test.
Calculating the window of opportunity for resection before
drainage becomes necessary. Given that there is little
consensus as to a level of hyperbilirubinaemia above
which biliary drainage is mandatory prior to resection,
several threshold values were used: 200, 300, 400 and
500 mmol/l. The calculated rate of increase in serum
bilirubin was used to predict the number of days it
would take for levels to rise from the presenting value
to each threshold value if left untreated. Linear
regression analysis was then performed using bilirubin
on presentation (B0) as the predictor and number of
days (D) as the response with 95% confidence inter-
vals being calculated. In this way it was hoped to
identify the mean length of time that a patient with a
specific bilirubin level would take to reach the thresh-
old if biliary drainage were not performed. All calcula-
tions were made using Minitab Statistical Software.
Results
Demographics
In total, 111 patients with pancreatic or periampullary
malignancy were included, 65 males and 46 females,
with a median age of 69 years (range 3489).
Diagnoses were confirmed on histology/cytology
(n/75) or strong radiological evidence and raised
tumour markers (n/36). Resectable disease on sta-
ging by CT scan was found in 66 patients (59%).
Bilirubin levels on presentation and rates of increase
Median serum bilirubin when first measured was
160 mmol/l (9.4 g/dl) in all patients with an inter-
quartile range (IQR) of 107239 mmol/l. This was not
significantly different for those with resectable disease
on staging in whom the median level was 166.5 mmol/l
(IQR 112.5202 mmol/l, p/0.32, Student’s t test).
Table I shows the range of bilirubin levels when first
Table I. Serum bilirubin levels at first measurement.
Serum bilirubin
(mmol/l)
Number (%) of patients
(Total/111)
5/50 10 (9%)
51100 15 (14%)
101150 29 (26%)
151200 14 (13%)
201250 19 (17%)
251300 7 (6%)
/300 17 (15%)
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measured. The subsequent median rate of increase in
bilirubin levels was 13.1 mmol/l/day (IQR 9.530.3).
This did not vary significantly between resectable
tumours (median 10.9) and non-resectable tumours
(median 15.6) (p/0.25, Student’s t test). In addition,
linear and logistic regression analysis confirmed no
relationship between the level on presentation and the
subsequent rate of increase.
Predicting the time for bilirubin levels to rise above
threshold levels
When the predicted length of time for bilirubin levels
to rise above each threshold level was plotted against
bilirubin on presentation, an inverse linear relation-
ship was demonstrated. Figure 1 shows an example of
this relationship for a threshold set at 300 mmol/l. The
mean predicted number of days, with 95% confidence
intervals, for levels to rise to each threshold level is
shown in Table II for several arbitrary bilirubin levels
on presentation.
Discussion
The presence of obstructive jaundice, if untreated,
results in nutritional, metabolic and septic complica-
tions. Surgery in jaundiced patients has been shown to
be associated with an increased risk of complications
that increases with the depth of jaundice [14]. Less
jaundiced patients are therefore more suitable for
surgery without preoperative drainage. In our study,
the median bilirubin on presentation was 160 mmol/l
and/60% of our patients with malignant distal
biliary obstruction presented with a serum bilirubin
ofB/200 mmol/l. In only 15% of cases was the
presenting serum bilirubin over 300 mmol/l. Most
patients therefore, present with a level of jaundice that
would not necessarily preclude surgery without pre-
operative biliary drainage. Thus, a limited window of
opportunity exists in which to diagnose and stage
patients as quickly as possible so that early operation,
if indicated, may be carried out before progressive
jaundice makes drainage inevitable.
Choosing a threshold of hyperbilirubinaemia below
which most surgeons would be happy to avoid biliary
drainage prior to resection is difficult, since for
individual patients other factors including co-morbid-
ity will need to be taken into account. Many studies
have looked at the adverse effects of jaundice per se
and shown a higher rate of nutritional, septic and
subsequent surgical complications in more jaundiced
subjects [14,34]; however, none has suggested a
threshold below which surgery without drainage in the
non-septic patient is universally acceptable. If, for
example, a threshold of 300 mmol/l is employed, the
average patient would have B/2 weeks from presenta-
tion to breaching this level. Even if one were to reject
the idea of having a fixed threshold for surgery
without preoperative biliary drainage, knowing that
bilirubin increases by an average of approximately 100
mmol/l/week is useful data and is argument in itself for
prompt action and fast-track surgery if potentially
hazardous drainage procedures are to be avoided.
We have demonstrated that there is significant
variability in the rate of increase in serum bilirubin
levels after presentation and that this is independent
of the potential resectability of the obstructing
tumour. The predicted number of days for bilirubin
to breach each threshold level has wide confidence
intervals and can therefore only be used as a guide. It
does, however, reinforce the argument that in all cases
prompt investigation, staging and surgery are essential
if biliary drainage is to be avoided in as many cases as
possible. Processing patients this quickly from pre-
sentation to definitive surgery offers a considerable
challenge that has major resource implications in a
Figure 1. Linear regression plot of the number of days for serum
bilirubin to rise above 300 mmol/l (D) vs bilirubin levels on
presentation (B0).
Table II. Predicted interval in days between presentation and serum bilirubin rising above different threshold levels.
Threshold of serum
bilirubin level
(mmol/l)
Mean predicted days until levels rise above threshold (95% confidence interval)
at different presenting levels of serum bilirubin
50 mmol/l
(2.9 g/dl)
100 mmol/l
(5.8 g/dl)
160 mmol/l
(9.4 g/dl)
200 mmol/l
(11.7 g/dl)
250 mmol/l
(14.6 g/dl)
200 14 (1018) 9 (514) 3.5 (010) NA NA
300 23 (1631) 19 (928) 13 (125) 9 (022) 4 (019)
400 32 (1747) 28 (946) 22 (045) 18 (044) 14 (042)
500 41 (1964) 37 (965) 31 (065) 28 (066) 23 (066)
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modern health service. It does, however, have the
potential to reduce complications of biliary drainage
and to reduce days in hospital waiting for drainage
procedures or in treating complications.
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